SCHEDULES

SCHEDULE 2Relief for research and development: subjects of clinical trials

Amendments to Schedule 13 to FA 2002

3

(1)

Schedule 13 to FA 2002 (tax relief for expenditure on vaccine research etc) is amended as follows.

(2)

In paragraph 3 (qualifying expenditure on direct research and development), in sub-paragraph (5)—

(a)

omit the word “or” at the end of paragraph (b);

(b)

after that paragraph insert—

“(ba)

is incurred on relevant payments to the subjects of a clinical trial, or”.

(3)

In paragraph 5 (which applies certain definitions from Schedule 20 to FA 2000)—

(a)

in the heading, after “ “software or consumable items”,” insert “ “relevant payments to the subjects of a clinical trial”, ”;

(b)

in sub-paragraph (3), after paragraph (c) insert—

“(ca)

paragraph 6A (relevant payments to subjects of clinical trials);”.

(4)

In paragraph 9 (relevant expenditure of the sub-contractor), in sub-paragraph (3)—

(a)

omit the word “or” at the end of paragraph (b);

(b)

after that paragraph insert—

“(ba)

is incurred on relevant payments to the subjects of a clinical trial, or”.